Optimizing Outcomes in Patients With Inflammatory Bowel Diseases: The Critical Role of the GI Nurse
Source: Optimizing Outcomes in Patients With Inflammatory Bowel Diseases (IBD): The Critical Role of the GI Nurse

Slideset

Optimizing Outcomes in Patients With Inflammatory Bowel Diseases: The Critical Role of the GI Nurse

In this downloadable slideset, Karen A. Hanson, APRN, CN, and Joshua R. Korzenik, MD, review the critical role of the gastroenterology nurse in monitoring, evaluating, and communicating benefits and risks of treatment and applying strategies to improve adherence in patients with inflammatory bowel disease.
Format: Microsoft PowerPoint (.ppt)
File size: 2.04 MB
Date posted: 12/12/2016
  • Biosimilars: Addressing Uncertainties With a New Drug Class

    Kenneth G. Saag MD, MSc - 3/13/2017    2 comments / Last Comment: 4/24/2017
    Biosimilars promise increased access and decreased prices for patients in need of expensive biologics. However, as with any new category of drug, biosimilars face some uncertainties. Here’s my take.
  • Key Considerations for Using Biosimilars in IBD

    David T. Rubin MD - 6/6/2017    1 comment / Last Comment: 6/22/2017
    The role of biosimilars in the setting of IBD is growing. Here’s my take on some of the key things you need to consider when using these agents.